Lilly posts Phase 2b retatrutide renal results; registers tersolisib kidney PK studyNov 13Weekly roundup, 10 itemsabemaciclibanastrozole
Foghorn and Lilly halt FHD-909 program, company cuts 40% of workforceOct 1RestructuringEli LillyFoghorn Therapeutics Inc.